Rothschild Investment LLC’s Fulgent Genetics FLGT Stock Holding History

Rothschild Investment LLC’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82	Sell	4 -13	-76%	-$220	﹤0.01%	3533
2026 Q1	$270	Sell	17 -3	-15%	-$65	﹤0.01%	3244
2025 Q4	$525	Hold	20	–	–	﹤0.01%	2912
2025 Q3	$452	Sell	20 -15	-43%	-$309	﹤0.01%	2855
2025 Q2	$696	Buy	+35	New	+$682	﹤0.01%	2624
2025 Q1	–	Sell	-5	Closed	-$92	–	3044
2024 Q4	$92	Sell	5 -10	-67%	-$195	﹤0.01%	2910
2024 Q3	$326	Buy	15 +5	+50%	+$112	﹤0.01%	2593
2024 Q2	$196	Buy	+10	New	+$209	﹤0.01%	2494

Other funds holding FLGT

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CMF

Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Rothschild Investment LLC's FLGT Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Fulgent Genetics (FLGT) stake by 76% in Q2 2026, selling an estimated $220 and leaving 4 shares worth $82. The position accounts for ﹤0.01% of the portfolio, ranked #3533.

Rothschild Investment LLC first reported a position in FLGT in Q2 2024 and has held it in 8 quarters since. The position peaked at $696 in Q2 2025. 40 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

Rothschild Investment LLC held 4 shares of Fulgent Genetics worth $82 as of Q2 2026.
Rothschild Investment LLC sold 13 Fulgent Genetics shares in Q2 2026, an estimated $220.
Fulgent Genetics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3533 holding.
Rothschild Investment LLC first reported a position in Fulgent Genetics in Q2 2024 and has held it in 8 quarters since.
Rothschild Investment LLC's Fulgent Genetics position peaked at $696 in Q2 2025.
40 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.